Article
Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Nov 2010
Camidge D Ross, Kono Scott A, Flacco Antonella, Tan Aik-Choon, Doebele Robert C, Zhou Qing, Crino Lucio, Franklin Wilbur A, Varella-Garcia Marileila
Abstract excerpt
PURPOSE: Anaplastic lymphoma kinase (ALK) rearrangements, associated with sensitivity to an experimental ALK/MET inhibitor, occur in 3% to 5% of non-small cell lung cancers. Intratumoral fluorescence in situ hybridization (FISH) heterogeneity has been reported. We explored the heterogeneity basis, the requirements for accurately determining ALK FISH positivity, and the effect of enriching the tested population...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
